Thomas Goralski
Directeur des opérations chez Expression Analysis, Inc.
Profil
Thomas Goralski is Vice President of Laboratory Operations for Expression Analysis, Inc. Prior to Expression Analysis, he was Director of Production Biology for Perlegen Sciences, Inc. Previously, he held positions in DNA Sequencing and Microarray Operations at Incyte Genomics.
Dr. Goralski received a PhD in Molecular, Cellular and Develop Biology from Indiana University, Bloomington.
Postes actifs de Thomas Goralski
| Sociétés | Poste | Début |
|---|---|---|
Expression Analysis, Inc.
 Expression Analysis, Inc. Medical SpecialtiesHealth Technology Expression Analysis, Inc. supplies microarray services and solutions for clinical trials. It provides experimental design consultation, biologic sample preparation, sample processing, and statistical analysis services. The company was founded in September, 2001 by Steven Casey and is headquartered in Durham, NC. | Directeur des opérations | - |
Anciens postes connus de Thomas Goralski
| Sociétés | Poste | Fin |
|---|---|---|
| Incyte Genomics Inc. /Micoarray Operations/ | Corporate Officer/Principal | - |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Expression Analysis, Inc.
Expression Analysis, Inc. Medical SpecialtiesHealth Technology Expression Analysis, Inc. supplies microarray services and solutions for clinical trials. It provides experimental design consultation, biologic sample preparation, sample processing, and statistical analysis services. The company was founded in September, 2001 by Steven Casey and is headquartered in Durham, NC. | Health Technology |
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
| Incyte Genomics Inc. /Micoarray Operations/ | Commercial Services |
